R. Paul Robertson, M.D. completed his doctoral work at Creighton University followed by completion of an Internal Medicine residency and an Endocrinology and Metabolism fellowship at the University of Washington in 1973. He continued at the University of Washington where he became Professor of Medicine and Pharmacology and Head, Division of Clinical Pharmacology in 1980. In i983 he became Professor and Vice-Chairman of Medicine at the University of Colorado. In 1986 he moved to the University of Minnesota where he became Professor of Medicine and Cell Biology, the Pennock Chair for Diabetes Research, and Director of the Diabetes, Endocrinology, and Metabolism Division. He has been elected to the American Society of Clinical Investigation and the Association of American Physicians. He has been Editor of Diabetes and of the American Journal of Physiology, Chair of the NIH Metabolism Study Section, and is a member of the Journal of Biological Chemistry Editorial Board and Editor-in-Chief of Endocrine Reviews. He has received the Moses Barron Award, the William C. Stadie Award, the Albert Renold Medal, and a Banting Medal in 2009 as President for Medicine and Science of the American Diabetes Association. He is the immediate Past President and Scientific Director of PNDRI and currently is Professor of Pharmacology and Medicine at the University of Washington. His research interests focus on glucose regulation of pancreatic islet gene expression and the abnormal consequences on gene expression caused by glucose toxicity. He is also very actively involved in metabolic studies of type 1 diabetic patients who have successfully received pancreas and pancreatic islet transplantation. He has published over 320 manuscripts. His research studies are currently funded by two NIH NIDDK R01 awards and an ADA mentor-based postdoctoral fellowship.